ICCM
Income statement / Annual
Last year (2025), Icecure Medical Ltd's total revenue was $3.38 M,
an increase of 2.67% from the previous year.
In 2025, Icecure Medical Ltd's net income was -$15.06 M.
See Icecure Medical Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$3.38 M |
$3.29 M |
$3.23 M |
$3.09 M |
$4.14 M |
$4.08 M |
$1.66 M |
$1.07 M |
$689.38 K |
$625.49 K |
| Cost of Revenue |
$2.15 M
|
$1.84 M
|
$1.93 M
|
$1.64 M
|
$1.94 M
|
$1.43 M
|
$1.08 M
|
$623.17 K
|
$514.44 K
|
$403.99 K
|
| Gross Profit |
$1.23 M
|
$1.45 M
|
$1.30 M
|
$1.45 M
|
$2.20 M
|
$2.66 M
|
$576.41 K
|
$448.73 K
|
$174.93 K
|
$221.49 K
|
| Gross Profit Ratio |
0.36
|
0.44
|
0.4
|
0.47
|
0.53
|
0.65
|
0.35
|
0.42
|
0.25
|
0.35
|
| Research and Development Expenses |
$7.43 M
|
$7.10 M
|
$8.27 M
|
$9.12 M
|
$5.88 M
|
$4.08 M
|
$2.85 M
|
$1.94 M
|
$1.50 M
|
$1.66 M
|
| General & Administrative Expenses |
$7.85 M
|
$8.91 M
|
$4.17 M
|
$5.86 M
|
$4.13 M
|
$1.76 M
|
$1.32 M
|
$1.07 M
|
$1.02 M
|
$943.95 K
|
| Selling & Marketing Expenses |
$1.04 M
|
$1.14 M
|
$4.44 M
|
$3.20 M
|
$1.92 M
|
$1.11 M
|
$1.02 M
|
$612.55 K
|
$319.66 K
|
$717.00 K
|
| Selling, General & Administrative Expenses |
$8.89 M
|
$10.05 M
|
$8.60 M
|
$9.06 M
|
$6.04 M
|
$2.87 M
|
$2.34 M
|
$1.68 M
|
$1.34 M
|
$1.66 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$70.59 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$16.32 M
|
$17.15 M
|
$16.88 M
|
$18.18 M
|
$11.92 M
|
$7.02 M
|
$5.19 M
|
$3.62 M
|
$2.84 M
|
$3.33 M
|
| Cost And Expenses |
$18.47 M
|
$18.99 M
|
$18.81 M
|
$19.82 M
|
$13.86 M
|
$8.45 M
|
$6.27 M
|
$4.24 M
|
$3.35 M
|
$3.73 M
|
| Interest Income |
$0.00
|
$378.00 K
|
$924.00 K
|
$0.00
|
$0.00
|
$412.00 K
|
-$178.76 K
|
$556.00
|
$1.95 K
|
$3.90 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$239.00 K
|
$171.00 K
|
$38.67 K
|
$22.81 K
|
$73.15 K
|
$61.16 K
|
$154.94 K
|
| Depreciation & Amortization |
$295.00 K
|
$332.00 K
|
$323.00 K
|
$248.00 K
|
$127.00 K
|
$63.00 K
|
$155.37 K
|
$30.80 K
|
$33.38 K
|
$54.07 K
|
| EBITDA |
-$14.80 M |
-$15.36 M |
-$15.25 M |
-$16.49 M |
-$9.60 M |
-$4.08 M |
-$4.60 M |
-$3.42 M |
-$2.75 M |
-$3.03 M |
| EBITDA Ratio |
-4.38
|
-4.67
|
-4.72
|
-5.35
|
-2.32
|
-1
|
-2.77
|
-3.19
|
-3.99
|
-4.85
|
| Operating Income Ratio |
-4.47
|
-4.77
|
-4.82
|
-5.43
|
-2.35
|
-1.07
|
-2.78
|
-2.96
|
-3.87
|
-4.96
|
| Total Other Income/Expenses Net |
$37.00 K
|
$378.00 K
|
$924.00 K
|
-$239.00 K
|
-$171.00 K
|
$412.00 K
|
-$165.18 K
|
-$363.76 K
|
-$210.90 K
|
-$166.64 K
|
| Income Before Tax |
-$15.06 M
|
-$15.32 M
|
-$14.65 M
|
-$16.98 M
|
-$9.90 M
|
-$4.69 M
|
-$4.77 M
|
-$3.53 M
|
-$2.88 M
|
-$3.27 M
|
| Income Before Tax Ratio |
-4.46
|
-4.65
|
-4.54
|
-5.5
|
-2.39
|
-1.15
|
-2.88
|
-3.3
|
-4.17
|
-5.23
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$86.77 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$15.06 M
|
-$15.32 M
|
-$14.65 M
|
-$17.22 M
|
-$10.07 M
|
-$4.78 M
|
-$4.76 M
|
-$3.53 M
|
-$2.88 M
|
-$3.27 M
|
| Net Income Ratio |
-4.46
|
-4.65
|
-4.54
|
-5.58
|
-2.43
|
-1.17
|
-2.87
|
-3.3
|
-4.17
|
-5.23
|
| EPS |
-0.24 |
-0.3 |
-0.32 |
-0.47 |
-0.35 |
-0.28 |
-0.35 |
-0.3 |
-0.46 |
-0.62 |
| EPS Diluted |
-0.24 |
-0.3 |
-0.32 |
-0.47 |
-0.35 |
-0.28 |
-0.35 |
-0.3 |
-0.46 |
-0.62 |
| Weighted Average Shares Out |
$63.58 M
|
$50.88 M
|
$45.64 M
|
$37.02 M
|
$28.55 M
|
$17.13 M
|
$13.62 M
|
$11.67 M
|
$6.26 M
|
$5.30 M
|
| Weighted Average Shares Out Diluted |
$63.58 M
|
$50.88 M
|
$45.64 M
|
$37.02 M
|
$28.55 M
|
$17.13 M
|
$13.62 M
|
$11.67 M
|
$6.26 M
|
$5.30 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
